ADIPOQ and endothelial dysfunction: Finally, adiponectin reductions are associated with increased CRP and other pro-inflammatory cytokines [18, 19], insulin resistance [19], elevated plasma triglycerides and lipoproteins [20], and endothelial dysfunction [21] in the general population.